Natus to debut BrainWatch point-of-care EEG solution at AES

MIDDLETON, Wis., Dec. 4, 2024 /PRNewswire/ -- Natus Medical Incorporated will debut its highly anticipated, FDA-cleared point-of-care EEG solution, BrainWatchtm, during the American Epilepsy Society Annual Meeting in Los Angeles Dec. 6-10.

BrainWatch received 510(k) clearance in November, setting the stage for Natus to collaborate further with industry-leading hospitals and healthcare facilities to determine the product's first users and gain valuable feedback prior to the official launch in early 2025.

"BrainWatch is designed to bring the reliability and trust of Natus EEG solutions into critical care environments," said Natus CEO Chris Landon. "And, because of its ease of use, BrainWatch will make high-quality EEG accessible to people across more communities while enabling remote, expert neurologist consultation."

BrainWatch can be set up in less than five minutes, allowing quick intervention in acute care environments and streamlining treatment decisions with neurology support to improve patient outcomes. It also leverages the NeuroWorks software platform trusted by more health systems and small practices worldwide, offering a seamless and familiar review experience with remote neurologist collaboration 24/7 from any web browser.

"Point-of-care EEG is a rapidly growing market that is estimated to be $98 million by 2027," stated Landon. "With BrainWatch, Natus aspires to set a new standard for reliable EEG in critical-care moments."

Along with the debut of BrainWatch at AES, Natus will showcase new products designed to advance what's next in neuro at booth #1819 at the Los Angeles Convention Center. These products include the latest NeuroWorks 10 software, autoSCORE AI, Trex HD Monitoring EZ-Case System, Moberg Multimodal Monitoring system, Disposable MR Conditional Electrodes and the new EC2+ conductive paste for EEG cup electrodes.

ABOUT NATUS 

Natus is trusted by healthcare providers around the globe as the solution source to screen, diagnose, and treat disorders affecting the brain, neural pathways, and sensory nervous systems. The best-in-class Natus solutions, including service, field support and education, enable clinicians to advance their standard of care, improving patient outcomes and quality of life. For more information on Natus, please visit www.natus.com/neuro.

CONTACT INFORMATION:   
Lisa Schuler
Phone: +1 612 528-1332
Email: [email protected]

SOURCE Natus Medical Incorporated